Search results for "H1"

showing 10 items of 1219 documents

Pharmacological investigation into the effects of histamine and histamine analogues on guinea-pig and rat colon in vitro.

1986

The effects of histamine and specific histamine agonists has been examined on isolated longitudinal colon strips of guinea-pig and rat. Histamine and 2-pyridyl-ethylamine but not 4 methylhistamine produced a concentration-related contractile response in the guinea-pig colon. The H1-antagonist clemizole antagonized competitively the effect of histamine but the H2-antagonist ranitidine did not modify the dose-response curve to histamine in the guinea-pig colon. Atropine, hexamethonium, prazosin and propranolol failed to modify the contractile response to histamine. Tone induced with KCl in guinea-pig isolated colon was not modified by histamine agonists even in tissues pretreated with clemizo…

medicine.medical_specialtyColonGuinea PigsHistamine AntagonistsHistamine H1 receptorIn Vitro TechniquesHistamine agonistPotassium Chloridechemistry.chemical_compoundHistamine receptorHistamine H2 receptorInternal medicinemedicineAnimalsHistamine H4 receptorPharmacologyMethylhistaminesMuscle SmoothRats Inbred StrainsClemizoleRatsEndocrinologychemistryReceptors Histamine4-MethylhistamineHistamineResearch ArticleHistamineMuscle Contraction
researchProduct

Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy.

2015

PD-1 checkpoint inhibitors are associated with a specific spectrum of immune-related adverse events. This spectrum is different from toxicities known for kinase inhibitors or cytotoxic drugs. Since PD-1 directed therapies show effectivity in an increasing number of malignant diseases, their clinical usage will increase rapidly. Therefore clinicians from different specialities such as medical oncology, internal medicine, family doctors and emergency unit staff should be aware of the adverse effects of PD-1 checkpoint inhibitors to avoid delays in diagnosis and treatment. Based on pooled data from pivotal trials as reported by the European Medicines Agency, the present paper reviews incidence…

medicine.medical_specialtyDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentProgrammed Cell Death 1 ReceptorMedizinAntineoplastic AgentsPembrolizumabAntibodies Monoclonal HumanizedB7-H1 Antigen03 medical and health sciences0302 clinical medicineRefractoryMonitoring ImmunologicNeoplasmsmedicineEndocrine systemHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineIntensive care medicineAdverse effectbusiness.industryAntibodies MonoclonalDisease ManagementGeneral MedicineImmunotherapymedicine.diseaseEarly DiagnosisNivolumabOncologyMethylprednisolone030220 oncology & carcinogenesisImmunologyNivolumabbusinessAdverse drug reactionImmunosuppressive Agentsmedicine.drugCancer treatment reviews
researchProduct

Antihistaminic and anticholinergic activities of mequitazine in comparison with clemizole

1988

Abstract The antihistamine and anticholinergic properties of mequitazine have been investigated and compared with those of clemizole. Both mequitazine and clemizole antagonized the effect of histamine in guinea-pig ileum competitively, the pA2 values calculated by Schild plot were 9.95 ± 0.44 for mequitazine and 10.54 ± 0.44 for clemizole. Mequitazine at 10−7 M produced a parallel shift of the dose-response curve to acetylcholine in the rat duodenum, clemizole and the lower doses of mequitazine failed to modify the effect of acetylcholine. The potency of mequitazine and clemizole as H1-histamine blockers is similar, but only mequitazine at highest concentration used showed anticholinergic a…

medicine.medical_specialtyDuodenummedicine.drug_classmedicine.medical_treatmentGuinea PigsPharmaceutical ScienceIn Vitro TechniquesBiologyParasympatholyticchemistry.chemical_compoundPhenothiazinesInternal medicinemedicineAnticholinergicAnimalsPotencyMequitazinePharmacologyParasympatholyticsMuscle SmoothRats Inbred StrainsAcetylcholineRatsClemizoleSchild regressionEndocrinologychemistryHistamine H1 AntagonistsBenzimidazolesAntihistamineHistamineHistamineMuscle Contractionmedicine.drugJournal of Pharmacy and Pharmacology
researchProduct

Following Hydrogen Cyanide in the Valencian Country (1907-1933): Risk, Accidents and Standards in Fumigation

2019

Abstract Pests had represented a major problem in agriculture for centuries, but the huge changes in the food chain around the late nineteenth century intensified their effects in a totally unprecedented way and many new chemical substances were introduced in the attempt to control them. In this paper I will focus on the implementation of hydrogen cyanide, a highly toxic pesticide which has not received particular consideration from researchers to date. I shall analyse the introduction of this pesticide in the Valencian Country and focus on the attention given to the safety of workers and consumers. I aim to examine the role of the poison in its different uses and analyse the impact of each…

medicine.medical_specialtyH10 Pests of plantsHistory of knowledgeHydrogen cyanideFumigationValencianOccupational safety and healthT01 Pollutionchemistry.chemical_compoundEnvironmental healthPolitical sciencemedicineB50 HistoryPesticidesT10 Occupational diseases and hazardsPublic healthCultural historyCyanidesOccupational healthPublic healthGeneral Engineeringlanguage.human_languagechemistryAccidentsF01 Crop husbandryN20 Agricultural machinery and equipmentlanguage
researchProduct

Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidin…

1992

125I-Aminopotentidine (125I-APT), a reversible probe of high specific radioactivity and high affinity and selectivity for the H2 receptor, was used to characterize and localize this histamine receptor subtype in human brain samples obtained at autopsy. On membranes of human caudate nucleus, specific 125I-APT binding at equilibrium revealed a single component, with a dissociation constant of 0.3 nM and maximal capacity of about 100 fmol/mg of protein. At 0.2 nM, 125I-APT specific binding, as defined with tiotidine, an H2-receptor antagonist chemically unrelated to iodoaminopotentidine, represented 40-50% of the total. Specific 125I-APT binding was inhibited by a series of typical H2-receptor…

medicine.medical_specialtyHistamine H1 receptorHippocampal formationBiologyBiochemistryGuanidinesIodine RadioisotopesCellular and Molecular Neurosciencechemistry.chemical_compoundHistamine receptorHistamine H2 receptorInternal medicinemedicineHumansReceptors Histamine H2Tissue DistributionReceptorHistaminergicBrainHuman brainEndocrinologymedicine.anatomical_structurechemistryHistamine H2 AntagonistsAutoradiographyHistamineJournal of neurochemistry
researchProduct

Causality-based diagnosis of histamine-related cardiorespiratory disturbances in surgical patients

1998

medicine.medical_specialtyNeurologyImmunologyPharmacology toxicologyHistamine ReleaseSkin Diseaseschemistry.chemical_compoundDouble-Blind MethodTachycardiaInternal medicineBradycardiamedicineHumansIntensive care medicineAnaphylaxisPharmacologybusiness.industryCardiorespiratory fitnessCausalityRheumatologyHistamine H2 AntagonistschemistryHypertensionHistamine H1 AntagonistsHypotensionbusinessHistamineHistamineSurgical patientsInflammation Research
researchProduct

Histamine-sensitive adenylate cyclase of human gastric mucosa: a model for H2-receptor excitation.

1978

Recent studies revealed that human gastric mucosa contains a histamine-sensitive adenylate cyclase which is almost completely localized within the acid-secreting area of the stomach. In an attempt to further characterize the effector system of histamine’s action, we compared the effects of H 1 — and H 2-receptor agonists upon the adenylate cyclase in human fundic gastric mucosa.

medicine.medical_specialtyNucleotidase activityAdenylate kinaseIn Vitro TechniquesCyclasechemistry.chemical_compoundHistamine H2 receptorInternal medicinemedicineGastric mucosaEthylaminesHumansheterocyclic compoundsPharmacology (medical)Receptors Histamine H2Receptors Histamine H1Pharmacologybusiness.industryEffectorStomachMethylhistaminesdigestive system diseasesStimulation Chemicalmedicine.anatomical_structureEndocrinologychemistryGastric MucosaReceptors HistaminebusinessHistamineResearch ArticleAdenylyl CyclasesHistamine
researchProduct

Treg activation status depends on psoriasis therapy regime

2020

medicine.medical_specialtybusiness.industryPsoriasismedicineMEDLINEHumansPsoriasisTh17 CellsDermatologymedicine.diseasebusinessT-Lymphocytes RegulatoryDermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity

2008

Despite as yet limited clinical effectiveness, dendritic cell (DC)-based immunotherapy remains a promising approach for the treatment of cancer, but requires further improvement in its immunostimulatory effectiveness. Potent anti-tumor immunity often depends on the induction of type 1 (T(H)1) immune responses. Therefore, we combined different DC maturation stimuli that are known to induce T(H)1 immunity [anti-CD40, interleukin (IL)-12, IL-18], with the aim to trigger a T(H)1 driven anti-tumor CTL response. When compared with untreated DC or DC treated with anti-CD40 alone, DC matured with anti-CD40 plus IL-12 and IL-18 expressed significantly more IFN-gamma and IL-12, induced enhanced CD8(+…

medicine.medical_treatmentAntineoplastic AgentsDermatologyCD8-Positive T-LymphocytesModels BiologicalBiochemistryMiceImmune systemAntigens NeoplasmmedicineAnimalsCD40 AntigensAntigen-presenting cellMolecular BiologyMice Inbred BALB Cbusiness.industryInterleukin-18InterleukinDendritic CellsImmunotherapyDendritic cellTh1 CellsInterleukin-12Tumor antigenMice Inbred C57BLImmune SystemImmunologyInterleukin 12ImmunotherapybusinessCD8Experimental Dermatology
researchProduct

Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge…

2009

Cryptosporidium parvum is an intracellular parasite causing enteritis which can become life-threatening in the immunocompromised host. CD4+ T cells and interferon (IFN)-gamma play dominant roles in host immune response to infection. However, effector mechanisms that are responsible for recovery from infection are poorly understood. In the present study we analyzed mice deficient in IFN-gamma or interleukin (IL)-12 in parallel to C57BL/6 wild type mice as models for murine cryptosporidiosis. Our results identified IFN-gamma as the key cytokine in the innate as well as adaptive immunity during primary and also challenge C. parvum infection. Furthermore, both Th1 and Th2 cytokines appear to co…

medicine.medical_treatmentImmunologyCryptosporidiosisBiologyInterferon-gammaMiceImmune systemTh2 CellsImmunityIleummedicineImmunology and AllergyAnimalsInterferon gammaCryptosporidium parvumMice KnockoutInterleukin-12 Subunit p40Interleukin-18InterleukinHematologyTh1 CellsAcquired immune systembiology.organism_classificationMice Inbred C57BLCytokineCryptosporidium parvumGene Expression RegulationGastric MucosaOrgan SpecificityImmunologyInterleukin 12medicine.drugImmunobiology
researchProduct